Cmed Clinical Services Appoints New Vice President of Global Medical and Regulatory Affairs
HORSHAM, UK — February 14th, 2012 – Cmed Clinical Services announced today the appointment of Geoff Fatzinger as Vice President of Global Medical and Regulatory Affairs.
Geoff joins Cmed Clinical Services from INC Research, a therapeutically focused global contract research organization (CRO), where he was Executive Director of Regulatory Affairs and Strategic Product Development. He brings to Cmed Clinical Services a wealth of global regulatory experience and professionalism from a career spanning more than 15 years. In this time, he has guided clients and projects to new levels of success in a variety of highly competitive industries, cutting-edge markets, and fast-paced environments. Drawing on this expertise, Geoff will prove invaluable in developing the new Medical and Regulatory Affairs group that is being established within Cmed Clinical Services.
“Geoff’s appointment is a key building block in our future business strategy” said David Connelly, Cmed CEO. “Geoff will be responsible for all global regulatory and medical activities for Cmed Clinical Services. His leadership, expertise and vision are hugely important qualities to build our global presence”.
“I am delighted to join Cmed Clinical Services at this exciting time in the company’s development” adds Geoff. “My job is to create a best in class global medical and regulatory affairs group that will provide a full cadre of strategic consulting and medical/regulatory services to clients worldwide. I am looking forward to the challenge, and making Cmed Clinical Services the industry’s first choice in quality partners for product development and product approvals.”
Geoff’s demonstrated record of regulatory and business accomplishments covers the U.S., Europe, Asia Pacific (with in depth experience in Japan, China, and Korea), and Middle East having lived and worked in many countries championing regulatory affairs. He is also a frequent lecturer on international regulatory affairs and regulatory laws, as well as a contributing member to several organizations including TOPRA and a lecturer at Cranfield for the Regulatory Affairs education programs.
